Organization
Clinica Universidad de Navarra
5 clinical trials
9 abstracts
2 posters
Poster
MCLA-129-CL01Abstract
Whole exome sequencing and machine learning germline analysis of individuals presenting with phenotypes of extreme high and low risk of developing tobacco-induced lung adenocarcinoma.Org: Center for Applied Medical Reseach (CIMA), Universidad de Navarra - CIMA LAB Diagnostics, Universitat Politècnica de València, University Hospital Carl Gustav Carus, Medical Clinic I, Technical University Dresden, Clinica Universidad de Navarra,
Abstract
Updated dose escalation results for ReFocus, a first-in-human study of highly selective FGFR2 inhibitor RLY-4008 in cholangiocarcinoma and other solid tumors.Org: MSKCC, Cleveland Clinic, Taussig Cancer Center, Fox Chase Cancer Center, Clinica Universidad de Navarra, Karolinska University Hospital,
Abstract
First-in-human study (FIH) of FS222, a next-generation tetravalent PD-L1/CD137 bispecific antibody: Safety, pharmacodynamics (PD), and antitumor activity in patients (pts) with advanced solid tumors including PD-1 refractory melanoma.Org: Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Medical Oncology Department, Hospital Universitario 12 De Octubre, Hospital Clinic of Barcelona, Hospital Clinic i Provincial de Barcelona,
Abstract
Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.Org: University Hospital of Schleswig Holstein, Klinikum Esslingen, University Hospital Rostock, Karolinska Institutet, Capio St. Göran’s Hospital,
Clinical trial
Evaluation of the Efficacy of Tolcapone as a Genotype-based Targeted Cognitive Enhancer in Schizophrenia, Based on the Polymorphism rs4680Status: , Estimated PCD: 2025-08-01
Clinical trial
An International Retrospective Observational Study Comparing Primary Cytoreductive Surgery With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Patients With Carcinoma of the Ovary, Fallopian Tubes and PeritoneumStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.Status: Recruiting, Estimated PCD: 2025-08-14
Clinical trial
Phase I Trial of DNX-2440 Oncolytic Adenovirus in Patients With Recurrent GlioblastomaStatus: Terminated, Estimated PCD: 2023-04-05
Clinical trial
Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.Status: Completed, Estimated PCD: 2021-01-31
Abstract
Identification of cytokines associated with response and cytokine release syndrome: Analysis of MagnetisMM-3 cohort A.Org: Arnie Charbonneau Cancer Institute, University of Calgary, University of Calgary, Clinica Universidad de Navarra, Pfizer SLU, Pfizer Oncology Division,
Abstract
Genomic analysis to identify determinants of inherent response and resistance to elranatamab in MagnetisMM-3 cohort A.Org: Arnie Charbonneau Cancer Institute, University of Calgary, University of Calgary, St. Vincent’s Hospital, University of Melbourne, University Medical Center of Hamburg-Eppendorf,
Abstract
MELODY (Methods for Localization of Different Types of Breast Lesions): A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET).Org: University Hospital Schleswig-Holstein Campus Lübeck, Die Filderklinik, Aberdeen Breast Unit, Clinica Universidad de Navarra, Department of Molecular Medicine and Surgery, Karolinska Institutet,
Abstract
Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study.Org: Sorbonne University and Saint-Antoine Hospital, Hôpital Saint-Antoine, INSERM UMRs938, Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics,
Abstract
Prognostic value of human leukocyte antigen G (HLA-G) expression in solid tumors: A systematic review and meta-analysis.Org: Hospital Clinico San Carlos, IdISSC, Velindre Cancer Centre, Velindre University NHS Trust, Clinica Universidad de Navarra, Princess Margaret Cancer Centre,